학술논문

Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum?
Document Type
Article
Source
In: World Journal of Clinical Cases. (World Journal of Clinical Cases, 16 July 2022, 10(20):6759-6768)
Subject
Language
English
ISSN
23078960